✦ LIBER ✦

The Effect of Denosumab on Bone Turnover Markers (BTM) in Postmenopausal Women With Osteoporosis

✍ Scribed by Steven Cummings; Andrea Wang; Javier San Martin; Mike McClung; Christiansen Claus; Cesar Libanati; Ethel Siris; Richard Eastell

Book ID: 116322749
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 54 KB
Volume: 46
Category: Article
ISSN: 8756-3282
DOI: 10.1016/j.bone.2010.01.056

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of denosumab on bone turnover ma

Effects of denosumab on bone turnover markers in postmenopausal osteoporosis

✍ Richard Eastell; Claus Christiansen; Andreas Grauer; Stepan Kutilek; Cesar Liban 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 272 KB 👁 1 views

## Abstract Denosumab, a fully human monoclonal antibody to RANKL, decreases bone remodeling, increases bone density, and reduces fracture risk. This study evaluates the time course and determinants of bone turnover marker (BTM) response during denosumab treatment, the percentage of denosumab‐treat

Dose–response study of denosumab on bone

Dose–response study of denosumab on bone mineral density and bone turnover markers in Japanese postmenopausal women with osteoporosis

✍ T. Nakamura; T. Matsumoto; T. Sugimoto; M. Shiraki 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 500 KB

Effect of denosumab on bone turnover mar

Effect of denosumab on bone turnover markers in postmenopausal osteoporosis: Initial response and subsequent release from suppression

✍ R. Eastell; M. Austin; J. San Martin; M.R. McClung; C. Christiansen; C. Libanati 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Effects of Denosumab on Bone Mineral Den

Effects of Denosumab on Bone Mineral Density and Bone Turnover in Postmenopausal Women

✍ Terri M. Wensel; Maryam M. Iranikhah; Teresa W. Wilborn 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB

Effects of alendronate and risedronate o

Effects of alendronate and risedronate on bone mineral density and bone turnover markers in late postmenopausal women with osteoporosis

✍ Aysegul Atmaca; Olcay Gedik 📂 Article 📅 2006 🏛 Springer Healthcare Communications 🌐 English ⚖ 279 KB

Effects of 3 years of lasofoxifene

Effects of 3 years of lasofoxifene treatment on bone turnover markers in women with postmenopausal osteoporosis

✍ Richard Eastell; David M. Reid; Slobodan Vukicevic; Kristine E. Ensrud; Andrea Z 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 448 KB